Key Highlights
•
Researchers identified tubeimoside-1 (TBM-1) as a potent inhibitor of the LAT4 amino acid transporter, which is frequently overexpressed in cancers and contributes to systemic methionine accumulation. This finding is significant because it establishes a foundation for developing LAT4-targeting therapeutics to restrict methionine uptake, a promising strategy for enhancing cancer therapy.
Source →
•
A new high-resolution atlas of the cancer microbiome, created from 16,369 tumor genomes, reveals that orodigestive cancers harbor complex multi-kingdom microbial communities that vary by site and subtype. This work is crucial because it links the tumor microbiome to host phenotype and tumor genomic context, offering new avenues for understanding cancer biology and potential therapeutic targets.
Source →
•
Scientists discovered that respiratory syncytial virus (RSV) uses a process called liquid-liquid phase separation to evade the immune system’s oligoadenylate synthetase-RNase L pathway. Understanding this immune evasion mechanism is important for developing new antiviral strategies and vaccines against RSV, a major cause of respiratory illness.
Source →
•
A global modeling study shows that a moratorium on deep-sea mining could unexpectedly intensify nickel extraction in some of the Earth’s most biodiverse tropical regions. This highlights hidden biodiversity costs associated with conservation policies aimed at protecting ocean ecosystems.
Source →
•
A large-scale meta-analysis of 180 years of data from the Broadbalk Experiment revealed that organic fertilisation boosts total soil organic carbon by 160% compared to a no-fertilisation control, vastly exceeding the 26% gain from inorganic fertilisers. This research is vital for climate mitigation and sustainable agriculture, demonstrating that long-term carbon sequestration depends not just on carbon inputs but also on microbial community traits and necromass dynamics.
Source →
Stay curious. Stay informed —
Science Briefing
